ANGIOTECH PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, after Year Five
ANGIOTECH PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $166.57 million as of 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2013-03-28
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $166.57M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2012-12-31 | $166.57M 10-K · filed 2013-03-28 |